Baclofen Withdrawal

Definition: A dysfunctional condition in which removal of baclofen, an inhibitory neurotransmitter, from the central nervous system (CNS) causes CNS excitation.

Pathophysiology of Baclofen Goldfrank’s 2015 )

Inhibitory neurotransmitter that acts as a GABA B receptor agonist

Has both presynaptic and postsynaptic inhibitory properties Presynaptic: prevents Ca 2+ influx Postsynaptic: increases K + efflux

Inhibition results in decreased muscle tone and muscle spasms

Withdrawal likely results from loss of chronic inhibitory effect on postsynaptic receptors

Withdrawal typically occurs 24-48 hours after discontinuation of the drug or a reduction in dose

Intrathecal Baclofen Pumps

Catheter is placed into the cerebrospinal fluid (CSF) in the subarachnoid space

Catheter is connected to a pump which is typically inserted into the lower abdominal wall. This pump has a reservoir that can be filled with baclofen

Pump delivers baclofen in small amounts into the CSF causing inhibition at the spinal level

Causes of Baclofen Withdrawal Stetkarova 2010 )

Baclofen dose reduction

Intrathecal Pump Issues Catheter dislodgement, kinking or migration Reservoir underfilling: can occur if reservoir “missed” during medication refill leading to placement of medication in “pocket” around pump Pump device malfunction



Presentation

Baclofen withdrawal mimics symptoms seen with other CNS depressant withdrawal syndromes

History The patient may report a reduction in baclofen dose or cessation of the drug Increased spasticity Fever Myalgias Neuropsychiatric Symptoms: confusion, altered mental status, visual hallucinations

Physical Examination Vital Sign Alterations Hypertension Tachycardia Hyperthermia Muscle rigidity Seizures



Differential Diagnosis

Sepsis

Alcohol withdrawal

Benzodiazepine withdrawal

Serotonin syndrome

Note: Consider baclofen withdrawal in any patient who presents with vital sign abnormalities and has an intrathecal pump.



Diagnostics

The diagnosis of baclofen withdrawal should be made on clinical grounds as there is no specific diagnostic test.

KUB X-ray Used to visualize mechanical dysfunction – catheter dislodgment, kinking or migration Will demonstrate spinal level of catheter

Pump interrogation Typically performed by neurosurgery, interventional pain management or rehabilitation medicine Will reveal if pump is malfunctioning or if reservoir needs to be refilled

Look for rhabdomyolysis Increasing spasticity in withdrawal can cause muscle breakdown which can lead to renal dysfunction Labs: Basic metabolic panel (for creatinine), urinalysis, creatinine kinase



Management

Initial supportive measures Basics: IV, O 2 (if hypoxic) and cardiac monitor Fluid resuscitation Patients have large insensible losses from fever, muscle spasm and increased respiratory rate Start with 20-30 cc/kg and repeat as needed Seizure management Similarly, to alcohol withdrawal, seizures should be suppressed with CNS sedating agents and not typical antiepileptic drugs (i.e. phenytoin) Benzodiazepines are the 1st line agents Hyperthermia Aggressive external cooling Reasonable to administer antibiotics, obtain blood cultures and treat presumptively for infection as it can be difficult to differentiate hyperthermia from fever secondary to infection. Rhabdomyolysis Stop ongoing muscle destruction – relieve spasticity (see below), treat hyperthermia Administer IV fluids to maintain kidney perfusion and urine output Monitor patients for electrolyte abnormalities, particularly hyperkalemia

Directed medical management Oral Baclofen is unlikely to be helpful in withdrawal because even with large doses, it is difficult to get adequate CSF levels Intrathecal Baclofen Optimal agent and route for treatment of baclofen withdrawal Options for administration Refill empty reservoir in functional pump without catheter obstruction Administer via catheter side port if pump malfunctioning but catheter intact Deliver via lumbar puncture ( Shirley 2006 Benzodiazepines Treats withdrawal symptoms similarly to role in alcohol withdrawal Expect that patient may require large doses to control symptoms Propofol infusion Consider starting infusion early in management prior to significant hemodynamic decompensation Patient may require airway management with adequate propofol dose to manage withdrawal Other Numerous medications have been used in case reports and case series Examples: Dantrolene, Tizanidine ( Ross 2011



Disposition

Balcofen withdrawal is a life-threatening syndrome and patients should be admitted to the ICU while arranging for definitive management

Pump or catheter malfunction typically requires neurosurgical intervention in the operating room

If an empty reservoir is identified and refilled, the patient may be able to be discharged if all signs and symptoms resolve

Take Home Points

Baclofen withdrawal from an intrathecal pump presents with hemodynamic instability, increased spasticity, fever and altered mental status. Consider the diagnosis in any patient with an intrathecal pump and the above symptoms.

Oral baclofen replacement is unlikely to treat the disorder as it does not achieve adequate CSF levels.

The optimal treatment for intrathecal baclofen withdrawal is administration of baclofen into the CSF but this can be technically difficult.

Treat baclofen withdrawal with escalating doses of benzodiazepines and consider propofol infusion for patients who continue to decline.

Read More:

Link Rao R.B. (2015). Special Considerations. In Hoffman R.S., Howland M, Lewin N.A., Nelson L.S., Goldfrank L.R. (Eds), Goldfrank’s Toxicologic Emergencies, 10e. Chidester S, Smith S. Baclofen pump complications. The NYS Poison Centers Toxicology Letter 2011; 16(4): 1-12. Link

References:

Link Hamilton R.J. (2015). Withdrawal Principles. In Hoffman R.S., Howland M, Lewin N.A., Nelson L.S., Goldfrank L.R. (Eds), Goldfrank’s Toxicologic Emergencies, 10e. Stetkarova I et al. Procedure- and device-related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review. Neurorehabil Neural Repair. 2010;24(7):609-619. PMID: 20233964 Shirley KW et al. Intrathecal baclofen overdose and withdrawal. Pediatr Emerg Care. 2006;22(4):258-261. PMID: 16651918 Ross J et al. Acute Intrathecal Baclofen Withdrawal: A Brief Review of Treatment Options. Neurocrit Care. 2011;14(1):103-108. PMID: 20717751

Post Peer Reviewed By: Salim Rezaie (Twitter: @srrezaie)